Galavit powder 50mg 5pcs

As an immunomodulatory and anti-inflammatory agent in the complex therapy of immunodeficiency conditions in adults and adolescents from 12 years of age:
- infectious and inflammatory urogenital diseases (urethritis of chlamydial and trichomonas etiology, chlamydial prostatitis, acute and chronic salpingoophoritis, endometritis);
- purulent-inflammatory diseases of the pelvic organs;
- chronic recurrent diseases caused by the herpes virus;
- diseases caused by the human papillomavirus;
- postoperative rehabilitation of patients with uterine fibroids;
- complications of the postoperative period in women of reproductive age;
- postoperative purulent-septic complications and their prevention (including in cancer patients);
- chronic recurrent furunculosis, erysipelas;
- inflammatory diseases of the mucous membrane of the mouth and throat, periodontal diseases;
- peptic ulcer of the stomach and duodenum;
- viral hepatitis;
- asthenic conditions, neurotic and somatoform disorders, decreased physical performance (including among athletes); mental, behavioral and post-withdrawal disorders in alcohol and drug addiction.
In adults and adolescents over 12 years of age in monotherapy:
- chronic urogenital infections, including during immunorehabilitation measures during the inter-relapse period in order to maintain clinical remission;
- acute and chronic infectious and inflammatory diseases of the gastrointestinal tract, accompanied by intoxication and/or diarrhea.
As an immunomodulatory and anti-inflammatory agent in the complex therapy of immunodeficiency conditions in children over 6 years of age:
- frequent recurrent diseases of the respiratory tract and ENT organs of bacterial and viral etiology (frequent ARVI, bronchitis, pneumonia, chronic tonsillitis, chronic otitis media, chronic adenoiditis).
- purulent surgical diseases (burn lesions, recurrent furunculosis, chronic osteomyelitis, gangrenous appendicitis with omentitis, peritonitis, purulent pleurisy).

Intramuscularly. Before administration, the drug is diluted in 2 ml of water for injection or 0.9% sodium chloride solution. The solution obtained during dilution cannot be stored. Methods of use, doses, duration of use and frequency of subsequent courses of therapy are determined by the doctor depending on the diagnosis, severity of the disease, and age of the patient.
In adults and adolescents over 12 years of age in complex therapy:
- for urogenital diseases - urethritis of chlamydial and trichomonas etiology, chlamydial prostatitis: 1 day 100 mg twice, then 100 mg every other day. A course of 10-15 injections (depending on the severity of the pathological process).
- for salpingoophoritis, endometritis in the acute period: 2 days, 200 mg once a day, then 100 mg at intervals of 72 hours, the duration of use depends on the severity of the disease. There are a total of 20 injections per course. In the chronic period: 5 days, 100 mg once a day, then 100 mg every 72 hours. Course of 20 injections.
- for acute and chronic purulent diseases of the pelvic organs: in the acute period - 1 day 200 mg once, 3 days 100 mg daily, then 100 mg every other day 5 injections. Course of 10 injections. In the chronic period - 5 days, 100 mg once a day, then 100 mg every 72 hours. Course of 20 injections.
- for chronic recurrent diseases caused by the herpes virus: 100 mg daily for 5 injections, then 100 mg every other day for 15 injections.
- for diseases caused by the papilloma virus: 5 days, 100 mg once a day, then 100 mg every other day, 15 injections. Course of 20 injections.
- for postoperative rehabilitation of patients with uterine fibroids and complications of the postoperative period in women of reproductive age: 5 days, 100 mg once a day, then 100 mg every other day. Course of 15 injections.
- for the prevention and treatment of postoperative infectious complications in the pre- and postoperative period (including in cancer patients): prescribed 100 mg once a day, 5 injections before surgery, 5 after surgery, 100 mg every other day, and 5 injections of 100 mg every 72 hours. For severe disease, the initial dose is 200 mg once or 100 mg 2 times a day. Course of 20 injections.
- for chronic recurrent furunculosis, erysipelas: 5 days, 100 mg once a day, then 100 mg every other day. Course of 20 injections.
- for inflammatory diseases of the mucous membrane of the mouth and throat, periodontal diseases: initial dose of 100 mg daily for 5 injections, then 100 mg at intervals of 72 hours. Course of 15 injections.
- for gastric and duodenal ulcers in the acute period: 2 days, 200 mg once a day, then 100 mg at intervals of 72 hours. A course of 15-25 injections. In the chronic period: 5 days, 100 mg once a day, then 100 mg every 72 hours. Course of 20 injections.

- for viral hepatitis: the initial dose is 200 mg once, then 100 mg 2 times a day until the symptoms of intoxication and inflammation subside. Subsequent continuation of the course of 100 mg at intervals of 72 hours. Course 20 - 25 injections.
- for asthenic conditions, neurotic and somatoform disorders, for mental, behavioral and post-abstinence disorders, in patients with alcohol and drug addiction: 5 days, 100 mg daily, then 100 mg every 72 hours. A course of 15-20 injections. To increase physical performance: 100 mg every other day - 5 injections, then 100 mg every 72 hours, course up to 20 injections.
In adults and adolescents over 12 years of age in monotherapy:
- chronic urogenital infections, including when carrying out immunorehabilitation measures during the inter-relapse period in order to maintain clinical remission: 100 mg every other day for a course of 10 injections.
- acute and chronic infectious and inflammatory diseases of the gastrointestinal tract, accompanied by intoxication and/or diarrhea: 200 mg once, then 100 mg 2 times a day until the symptoms of intoxication subside. It is possible to subsequently continue the course of 100 mg at intervals of 72 hours. A course of 20-25 injections.
In children over 6 years of age:
- for frequent recurrent diseases of the respiratory tract and ENT organs of bacterial and viral etiology (frequent ARVI, bronchitis, pneumonia, chronic tonsillitis, chronic otitis, chronic adenoiditis): children from 6 to 11 years old, one injection of 50 mg daily for 5 days, then 50 mg once a day every other day for 10 - 15 days. A course of 10-15 injections. Children aged 12-18 years - treatment according to the same regimen in the form of intramuscular injections of 100 mg.
- for purulent surgical diseases (burn lesions, recurrent furunculosis, chronic osteomyelitis, gangrenous appendicitis with omentitis, peritonitis, purulent pleurisy): children from 6 to 11 years old, one injection of 50 mg daily - 5 days, then one injection of 50 mg every other day within 10 - 15 days. Course 10-15 injections; children aged 12-18 years - treatment is carried out according to the same scheme in the form of intramuscular injections of 100 mg. When dressings, it is desirable to use the drug Galavit externally in the form of dressings with sterile wipes moistened with a 1% solution of the drug in water for injection (in dressings with mash or water-soluble ointment dressings).
If there is no improvement after treatment, or symptoms worsen, or new symptoms appear, you should consult your doctor. Use the drug only according to the indications, the method of use and in the doses indicated in the instructions for use.